Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials; Draft Guidance for Industry; Availability

NonrulemakingNoticeFDA_FRDOC_0001-14302
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 24, 2026
Agency
Food and Drug Administration (FDA)